Micro Labs Limited is recalling 118,080 bottles of Telmisartan Tablets (40mg), a prescription medication used to treat high blood pressure. The recall was issued because the tablets failed stability testing for blend uniformity, meaning the active ingredients may not be evenly distributed throughout each tablet. If you are taking this medication, you should contact your healthcare provider or pharmacist to discuss your treatment before you stop taking the tablets.
The failure in blend uniformity means that some tablets may contain too much or too little of the active medication. This could lead to inconsistent blood pressure control or an increased risk of side effects.
You have 2 options:
Quantity: 118,080 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.